Medicus Pharma (MDCX) Enterprise Value (2023 - 2026)
Medicus Pharma's (MDCX) quarterly Enterprise Value came in at -$8.6 million in Q4 2025, down 106.52% YoY from $131.8 million in Q4 2024, and down 0.51% on a QoQ basis from -$8.6 million in Q3 2025.
Medicus Pharma (MDCX) Enterprise Value (2023 - 2026) Analysis & Trends
Medicus Pharma (MDCX) has 3 years of Enterprise Value data on file, last reported at -$8.6 million in Q4 2025.
- Quarterly Enterprise Value fell 106.52% year-over-year to -$8.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$8.6 million (down 106.52% YoY) and the FY2025 annual result came in at -$8.6 million, down 106.52% from the prior year.
- Enterprise Value eased to -$8.6 million in Q4 2025, from -$8.6 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$1.7 million in Q4 2023 to a low of -$9.7 million in Q2 2025.
- A 3-year average of -$6.1 million and a median of -$6.4 million in 2024 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value sank 142.21% — and 2025, when it plunged 106.52%.
- Tracing MDCX's Enterprise Value over 3 years: stood at -$1.7 million in 2023, then tumbled by 142.21% to -$4.2 million in 2024, then sank by 106.52% to -$8.6 million in 2025.
- The last three Enterprise Value figures came in at -$8.6 million (Q4 2025), -$8.6 million (Q3 2025), and -$9.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | -20.76 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | -6.52 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | -7.09 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | -7.69 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -4.90 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | -13.99 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | -3.26 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | -11.40 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | -4.80 Bn |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - | -15.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -15.14 Mn |
| Dec 31, 2025 | -8.60 Mn |
| Sep 30, 2025 | -8.56 Mn |
| Jun 30, 2025 | -9.67 Mn |
| Mar 31, 2025 | -3.98 Mn |
| Dec 31, 2024 | -4.16 Mn |
| Dec 31, 2023 | -1.72 Mn |